Issues of triple therapy of chronic obstructive pulmonary disease. Comments to the algorithm. A resolution of expert panel, June 13, 2018,...
Авдеев С. Н., Невзорова В. А., Куделя Л. М., Кондрашова Н. М., Суханова Г. И., Кинyайкин М. Ф., Наумова И. В., Шкуратов А. Г.
Пульмонология
Т. 29, Вып. 3, С. 365-374
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.18093/0869-0189-2019-29-3-365-374
Аннотация:
Minimizing the risk of exacerbations of chronic obstructive pulmonary disease (COPD) along with symptoms control are the most important therapeutic tasks in COPD. The effective solution of this problem is still being discussed. The prevention of COPD exacerbations is of social and economic importance and should be the primary concern in the treatment of this disease. Unresolved problems in the treatment of COPD are low patient compliance to therapy and side effects of medication. According to recent guidelines, in case of persistent COPD exacerbations with patients receiving long-acting bronchodilators (LABA), the use of inhaled corticosteroids (ICS) must be considered; this reduces the incidence of moderate and severe COPD exacerbations, especially if a patient has a history of bronchial asthma or blood and/or sputum eosinophilia. Availability of LABA/LAMA and ICS/LABA fixed combinations in Russia provides two possible options to administer a free triple combination consisting of a si
Ключевые слова:
Combined therapy; Exacerbations of chronic obstructive pulmonary disease; Extra-fine ICS; Inhaled corticosteroids
bronchodilating agent; corticosteroid; long acting drug; Article; asthma; chronic obstructive lung disease; combination drug therapy; disease exacerbation; disease severity; eosinophilia; human; medical history; medication compliance; practice guideline
Язык текста: Русский
ISSN: 0869-0189
Авдеев С. Н. Сергей Николаевич 1968-
Невзорова В. А.
Куделя Л. М.
Кондрашова Н. М.
Суханова Г. И.
Кинyайкин М. Ф.
Наумова И. В.
Шкуратов А. Г.
Avdeev S. N. Sergej Nikolaevich 1968-
Nevzorova V. A.
Kudelya L. M.
Kondrashova N. M.
Sukhanova G. I.
Kinyaykin M. F.
Naumova I. V.
Shkuratov A. G.
Issues of triple therapy of chronic obstructive pulmonary disease. Comments to the algorithm. A resolution of expert panel, June 13, 2018, Vladivostok [Вопросы тройной терапии в лечении хронической обструктивной болезни легких. Комментарии к алгоритму. Резолюция Совета экспертов от 13.06.18 (Владивосток)]
Issues of triple therapy of chronic obstructive pulmonary disease. Comments to the algorithm. A resolution of expert panel, June 13, 2018,...
Текст визуальный непосредственный
Пульмонология
Научно-практический журнал "Пульмонология"
Т. 29, Вып. 3 С. 365-374
2019
Статья
Combined therapy Exacerbations of chronic obstructive pulmonary disease Extra-fine ICS Inhaled corticosteroids
bronchodilating agent corticosteroid long acting drug Article asthma chronic obstructive lung disease combination drug therapy disease exacerbation disease severity eosinophilia human medical history medication compliance practice guideline
Minimizing the risk of exacerbations of chronic obstructive pulmonary disease (COPD) along with symptoms control are the most important therapeutic tasks in COPD. The effective solution of this problem is still being discussed. The prevention of COPD exacerbations is of social and economic importance and should be the primary concern in the treatment of this disease. Unresolved problems in the treatment of COPD are low patient compliance to therapy and side effects of medication. According to recent guidelines, in case of persistent COPD exacerbations with patients receiving long-acting bronchodilators (LABA), the use of inhaled corticosteroids (ICS) must be considered; this reduces the incidence of moderate and severe COPD exacerbations, especially if a patient has a history of bronchial asthma or blood and/or sputum eosinophilia. Availability of LABA/LAMA and ICS/LABA fixed combinations in Russia provides two possible options to administer a free triple combination consisting of a si